The c-Myc-PKM2 axis, which plays critical role in oncogenic cellular proliferation in head and neck cancer (HNC), promotes glycolysis and chemotherapy resistance in HNC cells (Gupta et al. 2018). Here, PKM is linked to head and neck cancer.